ID: ALA3087935

Max Phase: Preclinical

Molecular Formula: C16H19N3O7P2S

Molecular Weight: 459.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)Oc1ccc(-c2cc3c(NC(P(=O)(O)O)P(=O)(O)O)ncnc3s2)cc1

Standard InChI:  InChI=1S/C16H19N3O7P2S/c1-9(2)26-11-5-3-10(4-6-11)13-7-12-14(17-8-18-15(12)29-13)19-16(27(20,21)22)28(23,24)25/h3-9,16H,1-2H3,(H,17,18,19)(H2,20,21,22)(H2,23,24,25)

Standard InChI Key:  QNLZGVQZBSCPCU-UHFFFAOYSA-N

Associated Targets(Human)

Geranylgeranyl pyrophosphate synthetase 715 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Farnesyl diphosphate synthase 1240 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 459.36Molecular Weight (Monoisotopic): 459.0419AlogP: 3.20#Rotatable Bonds: 7
Polar Surface Area: 162.10Molecular Species: ACIDHBA: 7HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.88CX Basic pKa: 3.94CX LogP: 0.06CX LogD: -2.81
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.33Np Likeness Score: -1.10

References

1. Leung CY, Park J, De Schutter JW, Sebag M, Berghuis AM, Tsantrizos YS..  (2013)  Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.,  56  (20): [PMID:23998921] [10.1021/jm400946f]

Source